Home
Conditions
Relapsing Remitting Multiple Sclerosis

Clinical trial condition

Relapsing Remitting Multiple Sclerosis

Explore clinical trials studying Relapsing Remitting Multiple Sclerosis. Study availability and eligibility vary by location and protocol.

84 public trials 6 recruiting studies

Refine in advanced search Browse all conditions

Relapsing Remitting Multiple Sclerosis trial results

Active, not recruiting

Functional Outcomes From Diets in Multiple Sclerosis

NCT05327322

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Washington University St Louis, Missouri, United States

View Trial Details

Active, not recruiting

Clinically Isolated Syndrome and Relapsing-Remitting Multiple Sclerosis

NCT04009005

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Clinically Isolated Syndrome, +7 more
Locations: University of Iowa Iowa City, Iowa, United States

View Trial Details

Active, not recruiting

Ocrelizumab VErsus Rituximab Off-Label at the Onset of Relapsing MS Disease

NCT04578639

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations: Haukeland University Hospital Bergen, Norway

Nordlandsykehuset HF Bodø, Norway

Vestre Viken sykehus Drammen, Norway

Sørlandet Sykehus Kristiansand, Norway

View Trial Details

Active, not recruiting

Serum Neurofilament Light in Multiple Sclerosis

NCT06282081

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations: Dent Neurologic Institute Amherst, New York, United States

View Trial Details

Completed

Study to Evaluate the Safety and Efficacy of PIPE-307 in Subjects With Relapsing-Remitting Multiple Sclerosis

NCT06083753

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations: Xenosciences Phoenix, Arizona, United States

Arizona Neuroscience Research, LLC Phoenix, Arizona, United States

Alta Bates Summit Medical Center Berkeley, California, United States

Colorado Springs Neurological Associates Colorado Springs, Colorado, United States

View all 21 locations

View Trial Details

Completed

Reduced Oligodendrocyte-specific Cytotoxicity and Ofatumumab Treatment

NCT05171972

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations: University of Southern California Los Angeles, California, United States

View Trial Details

Completed

Identification of Retinal Perivascular Inflammation in Patients With Multiple Sclerosis Using Adaptive Optics (RETIMUS)

NCT04289909

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +18 more
Locations: Institut du Cerveau et de la Moelle epiniere - Hopital Pitie Salpetriere Paris, France

View Trial Details

Completed

MS Relapses During COVID-19 Pandemic

NCT04858763

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, COVID-19, +19 more
Locations: Nottingham University Hospitals NHS Trust Nottingham, United Kingdom

View Trial Details

Completed

Serum Neurofilaments and GFAP in Atypical Multiple Sclerosis

NCT04201470

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +13 more
Locations: CHU Montpellier Montpellier, France

View Trial Details

Completed

Neuropsychological Management of Multiple Sclerosis: Benefits of a Computerised Semi-autonomous At-home Cognitive Rehabilitation Programme

NCT03471338

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations: University Hospital of Caen Caen, Calvados, France

View Trial Details

Relapsing Remitting Multiple Sclerosis

Relapsing Remitting Multiple Sclerosis trial results

Related conditions